Return to search

Bioscience joint venture launched

Solicitors Rosenblatt and Bridgehead Technologies, specialist due diligence and consultancy provider for healthcare companies, have formed a non-exclusive relationship designed to provide biotechnology and pharmaceutical companies, whether public or private, with a combination of legal and consultancy advice. The intention is to meet the need for export reports, licensing, intellectual property, fund raising and IPO work in a one-stop shop.

Rosenblatt was founded in 1989 and Bridgehead Technologies in 1994, the latter has offices in Cambridge and Melton Mowbray in the UK and in Lausanne.